Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?

Overview of attention for article published in Frontiers in immunology, June 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 37,716 followers.

RT @SWA66706602: @brucep13 Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? https://…

RT @SWA66706602: @brucep13 Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? https://…

@brucep13 Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? https://t.co/NHsyGQXwhD

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.